Socioeconomic Status Tied to Multisystem Inflammatory Syndrome in Children
FRIDAY, Feb. 19, 2021 -- Low socioeconomic status (SES), high social vulnerability index (SVI), and racial/ethnic minority are associated with multisystem inflammatory syndrome in children (MIS-C), according to a study published online Feb. 18 in Pediatrics.
Karina Javalkar, M.D., from Boston Children's Hospital, and colleagues conducted a retrospective case-control study at three academic centers from Jan. 1 to Sept. 1, 2020, to characterize the socioeconomic and racial/ethnic disparities impacting MIS-C. Cases of MIS-C were compared to five control groups: children with COVID-19, those assessed for MIS-C but did not meet case criteria, those hospitalized with febrile illness, those with Kawasaki disease, and children in Massachusetts. The associations for SES, SVI, and race and ethnicity with MIS-C diagnosis and clinical severity were examined.
Forty-three children were diagnosed with MIS-C: 44, 26, and 28 percent were Hispanic, Black, and White, respectively; 51 and 53 percent were in the lowest quartile for SES and the highest quartile for SVI, respectively. The researchers identified associations for lowest SES quartile (odds ratio, 2.2), highest SVI quartile (odds ratio, 2.8), and race/ethnic minority with MIS-C diagnosis. There were no associations observed for SES, SVI, or race/ethnicity with disease severity.
"Future studies should explore the underlying social, structural, economic, environmental, and genetic risk factors to allow for targeted interventions to support vulnerable pediatric populations most affected by MIS-C and improve health equity," the authors write.
© 2021 HealthDay. All rights reserved.
Posted: February 2021
Read this next
FRIDAY, Feb. 26, 2021 -- In a research letter published online Feb. 16 in Open Forum Infectious Diseases, cutaneous findings are described for multisystem inflammatory syndrome in...
THURSDAY, Feb. 18, 2021 -- Avacopan is noninferior, but not superior, to prednisone with respect to remission at week 26 for patients with antineutrophil cytoplasmic antibody...
THURSDAY, Jan. 28, 2021 -- For patients discharged after acute ischemic stroke (AIS), the risk for stroke-associated pneumonia (SAP) is reduced for those with psoriasis or other...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.